GNLX - GENELUX Corp
2.52
0 0%
Share volume: 131,516
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$2.52
0.00
0.00%
Summary score
41%
Profitability
43%
Dept financing
25%
Liquidity
58%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-117.07%
Return on assets
-26.71%
Return on sales
-74296.23%
Return on invested capital
142.32%
Total debt ratio
32.39%
Debt ratio change over timeo
-0.75%
Current Ratio
3.92%
Quick Ratio
3.01%
Cash Position Ratio
1.86%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-33.83%
Return on sales
-117650%
Return on invested capital
0%
Total debt ratio
29.46%
Debt ratio change over timeo
0%
Current Ratio
3.77%
Quick Ratio
0%
Cash Position Ratio
1.48%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-49.27%
Return on sales
-117650%
Return on invested capital
0%
Total debt ratio
39.33%
Debt ratio change over time
0%
Current Ratio
2.43%
Quick Ratio
0%
Cash Position Ratio
0.86%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-126.04%
Return on assets
-117.15%
Return on sales
-43031.43%
Return on invested capital
42.27%
Total debt ratio
-75.44%
Debt ratio change over time
-0.75%
Current Ratio
1.8%
Quick Ratio
2.34%
Cash Position Ratio
1.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GNLX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -117.07% | 12.23% | 10.41% | 0% |
| Return on assets | -26.71% | 4.74% | 3.19% | 1.73% |
| Return on sales | -74296.23% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 142.32% | 8.04% | 10.95% | 0% |
| Profitability | 25% | 76% | 60% | 29% |
| Total debt ratio | 32.39% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -0.75% | -20.57% | -85.61% | 17.33% |
| Dept financing | 9% | 21% | 16% | 50% |
| Current Ratio | 3.77% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.48% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 18% | 22% | 14% |
| Short-term ratios | GNLX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -33.83% | 6.06% | 4.18% | 1.7% |
| Return on sales | -117650% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 29.46% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 20% | 15% | 25% |
| Current Ratio | 3.77% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.48% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 37% | 33% | 21% |